Neumora Therapeutics Stock (NASDAQ: NMRA) stock price, news, charts, stock research, profile.
You can purchase shares of Neumora Therapeutics (NASDAQ:NMRA) through any online brokerage.
Other companies in Neumora Therapeutics’s space includes: Supernus Pharmaceuticals (NASDAQ:SUPN), Verona Pharma (NASDAQ:VRNA), WAVE Life Sciences (NASDAQ:WVE), Tarsus Pharmaceuticals (NASDAQ:TARS) and ANI Pharmaceuticals (NASDAQ:ANIP).
Neumora Therapeutics has a consensus price target of $22.88.
The stock price for Neumora Therapeutics (NASDAQ: NMRA) is $10.5 last updated December 19, 2024 at 4:00 PM EST.
There are no upcoming dividends for Neumora Therapeutics.
Neumora Therapeutics’s Q4 earnings are confirmed for Thursday, March 6, 2025.
There is no upcoming split for Neumora Therapeutics.
Neumora Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.